{"id":1468,"date":"2020-07-10T16:14:24","date_gmt":"2020-07-10T14:14:24","guid":{"rendered":"http:\/\/invivo.partners\/?post_type=portoflio_invivo&#038;p=1468"},"modified":"2025-01-16T09:19:45","modified_gmt":"2025-01-16T08:19:45","slug":"telum-therapeutics","status":"publish","type":"portoflio_invivo","link":"https:\/\/invivo.partners\/ca\/portoflio_invivo\/telum-therapeutics\/","title":{"rendered":"Telum Therapeutics"},"content":{"rendered":"\r\n<p class=\"wp-block-paragraph\">Telum Therapeutics \u00e9s una empresa de biologia sint\u00e8tica que desenvolupa nous tractaments per a les <strong>infeccions MDR<\/strong> causades per bacteris <strong>Gram negatius<\/strong>, basats en l&#8217;\u00fas d&#8217;enzims l\u00edtics dels bacteri\u00f2fags, anomenats <strong>enzibi\u00f2tics<\/strong>. L&#8217;empresa ha desenvolupat la <strong>plataforma APEX\u2122<\/strong>: <em>Advanced Phage-derived Enzybiotics from Exploration<\/em>, que permet el descobriment de nous enzibi\u00f2tics i l&#8217;enginyeria per a crear enzims l\u00edtics quim\u00e8rics.<\/p>\r\n\r\n\r\n\r\n<ul class=\"wp-block-list\">\r\n<li>CEO i cofundador: Roberto D\u00edez<\/li>\r\n<li>CFO i cofundador: Rub\u00e9n D\u00edez<\/li>\r\n<li>CSO: Chad Euler<\/li>\r\n<li>Ubicaci\u00f3: No\u00e1in (Navarra)<\/li>\r\n<li>P\u00e0gina web: <a href=\"https:\/\/telumtherapeutics.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">telumtherapeutics.com<\/a><\/li>\r\n<\/ul>\r\n","protected":false},"featured_media":0,"template":"","tipo_portfolio":[507],"class_list":["post-1468","portoflio_invivo","type-portoflio_invivo","status-publish","hentry","tipo_portfolio-invivoventures"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Telum Therapeutics - Invivo Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/invivo.partners\/ca\/portoflio_invivo\/telum-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Telum Therapeutics - Invivo Partners\" \/>\n<meta property=\"og:description\" content=\"Telum Therapeutics \u00e9s una empresa de biologia sint\u00e8tica que desenvolupa nous tractaments per a les infeccions MDR causades per bacteris Gram negatius, basats en l&#8217;\u00fas d&#8217;enzims l\u00edtics dels bacteri\u00f2fags, anomenats enzibi\u00f2tics. L&#8217;empresa ha desenvolupat la plataforma APEX\u2122: Advanced Phage-derived Enzybiotics from Exploration, que permet el descobriment de nous enzibi\u00f2tics i l&#8217;enginyeria per a crear enzims\" \/>\n<meta property=\"og:url\" content=\"https:\/\/invivo.partners\/ca\/portoflio_invivo\/telum-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Invivo Partners\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-16T08:19:45+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/invivo.partners\/ca\/portoflio_invivo\/telum-therapeutics\/\",\"url\":\"https:\/\/invivo.partners\/ca\/portoflio_invivo\/telum-therapeutics\/\",\"name\":\"Telum Therapeutics - Invivo Partners\",\"isPartOf\":{\"@id\":\"https:\/\/invivo.partners\/#website\"},\"datePublished\":\"2020-07-10T14:14:24+00:00\",\"dateModified\":\"2025-01-16T08:19:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/invivo.partners\/ca\/portoflio_invivo\/telum-therapeutics\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/invivo.partners\/ca\/portoflio_invivo\/telum-therapeutics\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/invivo.partners\/ca\/portoflio_invivo\/telum-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/invivo.partners\/ca\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Telum Therapeutics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/invivo.partners\/#website\",\"url\":\"https:\/\/invivo.partners\/\",\"name\":\"Invivo Capital\",\"description\":\"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.\",\"publisher\":{\"@id\":\"https:\/\/invivo.partners\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/invivo.partners\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/invivo.partners\/#organization\",\"name\":\"Invivo Capital\",\"url\":\"https:\/\/invivo.partners\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"contentUrl\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"width\":1200,\"height\":630,\"caption\":\"Invivo Capital\"},\"image\":{\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Telum Therapeutics - Invivo Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/invivo.partners\/ca\/portoflio_invivo\/telum-therapeutics\/","og_locale":"ca_ES","og_type":"article","og_title":"Telum Therapeutics - Invivo Partners","og_description":"Telum Therapeutics \u00e9s una empresa de biologia sint\u00e8tica que desenvolupa nous tractaments per a les infeccions MDR causades per bacteris Gram negatius, basats en l&#8217;\u00fas d&#8217;enzims l\u00edtics dels bacteri\u00f2fags, anomenats enzibi\u00f2tics. L&#8217;empresa ha desenvolupat la plataforma APEX\u2122: Advanced Phage-derived Enzybiotics from Exploration, que permet el descobriment de nous enzibi\u00f2tics i l&#8217;enginyeria per a crear enzims","og_url":"https:\/\/invivo.partners\/ca\/portoflio_invivo\/telum-therapeutics\/","og_site_name":"Invivo Partners","article_modified_time":"2025-01-16T08:19:45+00:00","twitter_card":"summary_large_image","twitter_misc":{"Temps estimat de lectura":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/invivo.partners\/ca\/portoflio_invivo\/telum-therapeutics\/","url":"https:\/\/invivo.partners\/ca\/portoflio_invivo\/telum-therapeutics\/","name":"Telum Therapeutics - Invivo Partners","isPartOf":{"@id":"https:\/\/invivo.partners\/#website"},"datePublished":"2020-07-10T14:14:24+00:00","dateModified":"2025-01-16T08:19:45+00:00","breadcrumb":{"@id":"https:\/\/invivo.partners\/ca\/portoflio_invivo\/telum-therapeutics\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/invivo.partners\/ca\/portoflio_invivo\/telum-therapeutics\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/invivo.partners\/ca\/portoflio_invivo\/telum-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/invivo.partners\/ca\/"},{"@type":"ListItem","position":2,"name":"Telum Therapeutics"}]},{"@type":"WebSite","@id":"https:\/\/invivo.partners\/#website","url":"https:\/\/invivo.partners\/","name":"Invivo Capital","description":"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.","publisher":{"@id":"https:\/\/invivo.partners\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/invivo.partners\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/invivo.partners\/#organization","name":"Invivo Capital","url":"https:\/\/invivo.partners\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/","url":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","contentUrl":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","width":1200,"height":630,"caption":"Invivo Capital"},"image":{"@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/portoflio_invivo\/1468","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/portoflio_invivo"}],"about":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/types\/portoflio_invivo"}],"wp:attachment":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/media?parent=1468"}],"wp:term":[{"taxonomy":"tipo_portfolio","embeddable":true,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/tipo_portfolio?post=1468"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}